Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05538780
Other study ID # 34987/10/21
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date January 1, 2022
Est. completion date January 1, 2023

Study information

Verified date September 2022
Source Tanta University
Contact ashraf abuhamama, PhD
Phone 0020403322645
Email ashraf.abohamama@med.tanta.edu.eg
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Transient tachypnea of the newborn (TTN) is the most common cause of respiratory distress in fullterm newborn. TTN is a diagnosis of exclusion, It is primarily diagnosed based on medical history and typical clinical presentation. Lung ultrasonography is an accurate, non invasive and reliable tool for diagnosing TTN. Cardiometry is presently the only tool to evaluate thoracic fluid content continuously and noninvasively at the bedside.


Recruitment information / eligibility

Status Recruiting
Enrollment 50
Est. completion date January 1, 2023
Est. primary completion date November 1, 2022
Accepts healthy volunteers No
Gender All
Age group 0 Days to 3 Days
Eligibility Inclusion Criteria: - fifty newborns with gestational age = 34 weeks (calculated from the first day of last menstrual period and using New Ballard score) diagnosed with TTN Exclusion Criteria: 1. Gestational age less than 34 weeks. 2. Major congenital abnormalities. 3. Congenital heart diseases. 4. Neonatal sepsis. 5. Neonatal pneumonia. 6. Other causes of respiratory distress (RD)

Study Design


Related Conditions & MeSH terms

  • Tachypnea
  • Transient Tachypnea of the Newborn

Locations

Country Name City State
Egypt Tanta University, faculty of medicine Tanta

Sponsors (1)

Lead Sponsor Collaborator
Tanta University

Country where clinical trial is conducted

Egypt, 

References & Publications (3)

Hammad Y, Hasanin A, Elsakka A, Refaie A, Abdelfattah D, Rahman SA, Zayed M, Hassabelnaby Y, Mukhtar A, Omran A. Thoracic fluid content: a novel parameter for detection of pulmonary edema in parturients with preeclampsia. J Clin Monit Comput. 2019 Jun;33(3):413-418. doi: 10.1007/s10877-018-0176-6. Epub 2018 Jun 23. — View Citation

Ibrahim M, Omran A, AbdAllah NB, Ibrahim M, El-Sharkawy S. Lung ultrasound in early diagnosis of neonatal transient tachypnea and its differentiation from other causes of neonatal respiratory distress. J Neonatal Perinatal Med. 2018;11(3):281-287. doi: 10.3233/NPM-181796. — View Citation

Paviotti G, De Cunto A, Moressa V, Bettiol C, Demarini S. Thoracic fluid content by electric bioimpedance correlates with respiratory distress in newborns. J Perinatol. 2017 Sep;37(9):1024-1027. doi: 10.1038/jp.2017.100. Epub 2017 Jul 27. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary change of thoracic fluid content measured by electrical cardiometry ( ICON®; Osypka Medical, Berlin, Germany) at enrollment and after 72 hours of birth
Primary change of ultrasound data: double-lung point, interstitial lung syndrome, and fuzziness of the pleural lines (A-lines) and pleural effusion. using Siemens Acuson X300 ultrasound machine ( Siemens Health Care GmbH, Erlangen, Germany ) at enrollment and after 72 hours of birth
See also
  Status Clinical Trial Phase
Recruiting NCT01206946 - Efficacy of Antenatal Steroids in Reducing Respiratory Morbidities in Late Preterm Infants Phase 2
Completed NCT01310153 - Effect of Supine or Prone Position After Caesarean Birth N/A
Active, not recruiting NCT04780412 - Efficacy of Misoprostol in Prevention of Neonatal Respiratory Morbidity in Parturient at Early Term Elective Caesarian Section Phase 3
Completed NCT01517958 - Lung Ultrasound to Diagnose Transient Tachypnea of the Newborn (TTN) Versus Respiratory Distress Syndrome (RDS) in Neonates N/A
Withdrawn NCT03499418 - Evaluation of the Prevalence of Persistent Pulmonary Hypertension in Neonates
Completed NCT01859533 - Positive End Expiratory Pressure With A T-piece Resuscitator For Near-Term and Term Infants With Respiratory Distress Phase 2
Completed NCT03208894 - Role of Salbutamol and Furosemide in TTN Phase 3
Recruiting NCT01858129 - Inhaled Corticosteroids for the Treatment of Transient Tachypnea of the Newborn Phase 2
Completed NCT01772381 - Dexamethasone in Prevention of Respiratory Morbidity in Elective Caesarean Section in Term Fetus N/A
Completed NCT01225029 - Fluid Management in Transient Tachypnea of the Newborn N/A
Recruiting NCT01270581 - High Flow Nasal Cannula Versus Bubble Nasal CPAP for the Treatment of Transient Tachypnea of the Newborn in Infants ≥ 35 Weeks Gestation N/A
Recruiting NCT06278415 - Physiologically Based Cord Clamping To Improve Neonatal Outcomes After Elective Cesarean Delivery N/A
Not yet recruiting NCT06200519 - Assessment of Diastolic Function During the Transitional Period and Infancy Using Serial Echocardiography
Completed NCT02965365 - PATET Ratio to Rule Out Transient Tachypnea of the Newborn N/A
Completed NCT04722016 - LUNG ULTRASONOGRAPHY DECREASES RADIATION EXPOSURE
Recruiting NCT06270823 - Reducing Respiratory Distress After Elective Caesarean Birth Through Knee-chest-flexion: a Randomized Controlled Trial N/A
Completed NCT03006354 - nHFOV Versus nCPAP in Transient Tachypnea of the Newborn N/A
Completed NCT05006235 - Inhaled Beta-2 Agonist Versus Epinephrine For Treatment of Transient Tachypnea of Newborn (TTN) Phase 1
Recruiting NCT03346343 - Pulmonary Function Using Non-invasive Forced Oscillometry N/A
Completed NCT03165305 - The Role of Sustained Inflation on Short Term Respiratory Outcomes in Term Infants N/A